MedPath

REPATHA

REPATHA

Approved
DIN Number

02446057

Drug Class

Human

Market Date

Sep 28, 2015

Company
HC

Amgen Canada Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02446057
AIG Number0157370001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
C10AX13 EVOLOCUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification24:06.24
Health Canada Classification

ACTIVE INGREDIENTS (1)

EVOLOCUMABActive
Strength: 140 MG / ML
Monograph: EVOLOCUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.